Related Experiment Video
Updated: Aug 13, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Deep Learning Enables Automated Detection of Mature B Cell Neoplasms by Flow Cytometry
Sulov Chalise1, Mikhail Roshal1, Qi Gao1
1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
We developed an automated deep learning system for diagnosing mature B-cell lymphomas using multiparameter flow cytometry. This AI tool achieves high accuracy and provides interpretable outputs for clinical use.
Area of Science:
- Computational Biology
- Hematology
- Artificial Intelligence
Background:
- Multiparameter flow cytometry is crucial for diagnosing mature B-cell lymphomas.
- Current manual analysis is time-consuming and prone to variability.
Purpose of the Study:
- To develop an automated deep learning system for B-cell neoplasm detection.
- To improve diagnostic accuracy and efficiency in flow cytometry analysis.
Main Methods:
- A three-stage deep learning architecture was employed.
- The system utilizes light-chain, cell-level, and sample-level modules.
- Evaluated on 3,070 clinical specimens including peripheral blood, bone marrow, and tissue samples.
Main Results:
- Achieved 97.5% case-level accuracy, 95.6% sensitivity, and 98.9% specificity.
- Predicted abnormal cell counts strongly correlated with expert manual counts (R²=0.962).
- Features supported lymphoma subtype prediction with an AUROC of 0.925.
Conclusions:
- Automated flow cytometry interpretation can achieve high diagnostic accuracy.
- The system provides transparent, verifiable outputs suitable for clinical integration.
- Deep learning enhances diagnostic capabilities for mature B-cell lymphomas.
More Related Videos
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018